301 results on '"Ishimaru, Fumihiko"'
Search Results
2. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study
3. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis
4. The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia
5. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia
6. Associations between acute and chronic graft-versus-host disease
7. Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score
8. Scoring system for optimal cord blood unit selection for single cord blood transplantation
9. Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT
10. Selection of Cord Blood Unit by CD34+ Cell and GM-CFU Numbers and Allele-Level HLA Matching in Single Cord Blood Transplantation
11. Criteria for storage of cord blood units at Japan's largest cord blood bank
12. Iron deficiency among Japanese whole‐blood donors measured by serum ferritin.
13. Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation
14. Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation
15. Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens
16. RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study
17. Development of the Umbilical Cord Blood Transplantation-Specific Non-Relapse Mortality Risk Assessment Score: A Study from the Donor/Source and Transplant Complication Working Groups of Jstct
18. Validation and Refinement of Day 28 Overall Response after Treatment for Acute Graft-Versus-Host Disease
19. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study
20. Effect of conditioning regimens and GVHD prophylaxis on the outcomes of umbilical cord blood transplantation performed with cyclophosphamide/total-body irradiation-based regimens
21. Scoring system for optimal cord blood unit selection for single cord blood transplantation
22. Development and validation of a scoring system to predict vasovagal reaction upon whole‐blood donation.
23. Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
24. Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
25. Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapy
26. Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphoma
27. Adverse events caused by cord blood infusion in Japan during a 5‐year period
28. Adverse events caused by cord blood infusion in Japan during a 5‐year period.
29. Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease
30. Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation
31. Total bacterial counts on oral mucosa after using a commercial saliva substitute in patients undergoing hematopoietic cell transplantation
32. Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia
33. The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis
34. Evaluation of xerostomia in hematopoietic cell transplantation by a simple capacitance method device
35. Antimicrobial effects of the saliva substitute, Oralbalance®, against microorganisms from oral mucosa in the hematopoietic cell transplantation period
36. Induction of TNF-α, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells
37. Establishment and characterization of new B-cell precursor leukemia cell line NALM-35
38. Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
39. Successful Treatment of Progressive NK cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
40. Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
41. WORKSHOP FOR THE HOME-VISIT NURSES FOCUSED ON BLOOD TRANSFUSION AT HOME
42. Syncopal‐type reactions tend to be delayed and result in falls among elderly blood donors
43. Factors Associated With Umbilical Cord Blood Collection Quality in Japan
44. Comfortable environment for blood donation lowers the rate of vasovagal reactions
45. With regard to our manuscripts on the commercial saliva substitute, Oralbalance®—its formula has been changed
46. Calcineurin Inhibitor—Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
47. Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies
48. Clustered Incidence of Acute Promyelocytic Leukemia During Gefitinib Treatment for Non-Small-Cell Lung Cancer: Experience at a Single Institution
49. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells
50. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.